Cymabay Therapeu Stock Price, News & Analysis

CBAY NASDAQ

Company Description

Cymabay Therapeu (NASDAQ: CBAY) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

CBAY stock has declined 100.0% over the past year.

This page provides a comprehensive overview of CBAY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-100%

Performance 1 year

$0.0

Market Cap

114.8M

Shares outstanding

Cymabay Therapeu (CBAY) stock. Over the past 12 months, the stock has lost 100.0%.

Latest News

View All

March 22, 2024

0.00%

Gilead Sciences Announces Completion of Acquisition of CymaBay

acquisition

March 4, 2024

-0.16%

CymaBay Announces European Medicines Agency Accepts for Review the Marketing Authorization Application for Seladelpar for the Treatment of Primary Biliary Cholangitis

February 28, 2024

-0.25%

CymaBay Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Corporate Update

earnings

February 21, 2024

-0.06%

The New England Journal of Medicine Publishes Positive Phase 3 RESPONSE Data of CymaBay's Seladelpar in Primary Biliary Cholangitis

clinical trial

February 20, 2024

-0.03%

CymaBay Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 12, 2024

+25.38%

CymaBay Announces FDA Acceptance of NDA and Priority Review for Seladelpar for the Treatment of Primary Biliary Cholangitis

clinical trial fda approval

Cymabay Therapeu has 10 recent news articles. Of the recent coverage, 2 articles coincided with positive price movement and 7 with negative movement. Key topics include acquisition, earnings, clinical trial, fda approval, conferences. View all CBAY news →

SEC Filings

View All

No SEC filings available for CBAY.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

CBAY Company Profile & Sector Positioning

Cymabay Therapeu (CBAY) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.